Home » Newsletters » BioWorld Science

BioWorld Science

May 5, 2010

View Archived Issues

Medivir identifies novel BACE1 inhibitors

Banyu and Merck & Co. disclose novel NFkappaB-inducing kinase inhibitors

Novel CGRP antagonists claimed by Merck & Co.

Merck & Co. discloses novel positive allosteric modulators of M1 receptors

Actelion identifies novel antibacterial agents

Novel CRAC inhibitor synthesized at Incozen Therapeutics

FDA approves Chagas' disease screening test

Affimed raises funds in Series C financing round

Omeros' OMS-103HP shows clinical benefits in phase II trial in arthroscopic meniscectomy surgery

TB Alliance and AstraZeneca enter collaboration agreement for TB drug discovery and development

BioSante reinitiates development of GVAX prostate cancer vaccine

Cullin-1 emerges as a potential biomarker for the early diagnosis of human melanoma

Antisense Therapeutics provides update on pipeline candidates

Preclinical data on nucleolin-binding peptide EP-302 support further development in cancer therapy

FDA approves new dosing guidance for Creon in patients with chronic pancreatitis and pancreatectomy

Antioxidant activity of dextromethorphan may be beneficial in retinitis pigmentosa

LiGluR gene therapy reinstates visual responses in inherited blindness models

K-V Pharmaceutical provides update on confirmatory trial of Gestiva

Pan-CDK inhibitor BAY-1000394 exhibits favorable pharmacologic profile in preclinical evaluation

King and Acura to submit an NDA for Acurox tablets without Niacin

NOXXON completes first phase I study of Spiegelmer NOX-A12

FDA issues complete response letter to Sepracor's NDA for Stedesa

Curis completes enrollment and treatment in phase I study of CUDC-101 in cancer

Celator reports data from phase II Cpx-351 study in acute myeloid leukemia

FDA grants Osiris orphan drug designation for Prochymal in type 1 diabetes

ImmunoCellular files orphan drug application for ICT-107

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...